Search

everythinglearnresearchcommunity

for

Search:↓

The research shows that hydrogen bonds greatly affect the crystal structure of a Finasteride derivative.

Researchers made two new compounds that could be used for medicine.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

New compounds may help treat prostate cancer by reducing cell growth.

Method accurately measures finasteride in human plasma.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Combination therapy improves hair growth in advanced hair loss.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

3α-androstanediol helps reduce age-related cognitive and mood declines in male rats, unlike testosterone.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

Using K2S2O8 as an oxidizing agent in a specific condition, we can make Finasteride with 96.3% yield and 99.6% purity. This method is also good for other compounds and is environmentally friendly.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

Minoxidil helps grow longer, thicker hair in bald scalps of stumptailed macaques, and early treatment is more effective.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.